CIK: 1261506 - Address: C/o Repligen Corporation, 41 Seyon St., Bldg 1, Ste 100, Waltham, MA 02453
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1112250003
S%wins0000

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/28/24 21:56
2/27/24
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-193193.350-1-187D
8/30/23 16:06
8/29/23
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-146171.380-1-184D
9/9/22 16:14
9/9/22
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-176227.170-1-176D
5/26/22 17:17
5/25/22
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-2,215150.510-15-1677D
11/12/21 17:12
11/10/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-1,262263.930-5-591D
11/4/21 17:41
11/2/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-729303.940-2-391D
9/15/21 17:46
9/14/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-81294.2600094D
9/2/21 16:29
9/1/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-982283.910-3-494D
8/19/21 16:42
8/17/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.m-4,818254.180-19-1794D
7/22/21 20:25
7/20/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-927202.100-5-4113D
7/22/21 18:53
7/13/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.ad-307202.230-2-1117D
7/15/21 17:17
7/13/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-307202.230-2-1117D
5/13/21 17:01
5/11/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-50176.85000115D
6/22/20 16:42
6/18/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-2,155115.200-19-16101D
5/21/20 21:08
5/20/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-72139.450-10119D
5/21/20 21:06
5/18/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.ad-220137.780-2-1120D
5/21/20 21:03
4/20/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.ad-1,276104.570-12-9121D
5/19/20 20:46
5/18/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-220137.780-2-1120D
5/11/20 20:23
5/8/20
ASRTAssertio Therapeutics, IncDEHealthDrugPharmaceutical PreparationsDawes Karen AILDS-130.79140-16-1685D
4/22/20 18:07
4/20/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-1,276104.570-12-9121D
2/24/20 17:51
2/21/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS-39598.700-4-3113D
6/19/19 19:00
6/17/19
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-10077.350-1-1117D
6/14/19 17:20
6/13/19
ASRTAssertio Therapeutics, IncDEHealthDrugPharmaceutical PreparationsDawes Karen AILDS-403.180-13-11100D
12/4/18 11:29
12/3/18
ASRTAssertio Therapeutics, IncDEHealthDrugPharmaceutical PreparationsDawes Karen AILDS.d-414.840-8-1742D
5/15/18 09:53
5/11/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-83641.800-20-1795D
3/22/17 17:20
3/21/17
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADS.d-8634.128-3-393D5392516650225

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact